News N4 Pharma Plc

Equities

Market Closed - London S.E. Other stock markets 16:35:04 02/05/2024 BST			5-day change	1st Jan Change
0.8 ^GBX	0.00%		-5.88%	-5.88%

04-25	N4 Pharma strikes partnership deal for intracellular delivery	AN
04-23	N4 Pharma loss widens but "great optimism" remains	AN

N4 Pharma strikes partnership deal for intracellular delivery	04-25	AN
N4 Pharma loss widens but "great optimism" remains	04-23	AN
N4 Pharma Plc Reports Earnings Results for the Full Year Ended December 31, 2023	04-23	CI
N4 Pharma sees potential in Nuvec delivery method for cancer treatment	04-18	AN
N4 Pharma’s In Vivo Testing Shows Nuvec’s Potential as Oral Delivery System	04-18	MT
Police Arrest Two Over Attempt to Kill Murder Case	04-16	AQ
N4 Pharma's In-vitro Study Shows Nuvec's Versatility in Inhibiting Cancer Cells	02-15	MT
N4 Pharma shares rise on "encouraging" Nuvec research	02-15	AN
AIM WINNERS & LOSERS: DSW warns on earnings amid tepid M&A markets	02-15	AN
N4 Pharma plc Provides In-Vitro siRNA Update	02-15	CI
N4 Pharma's Nuvec Granted Patent in India	01-19	MT
N4 Pharma gets India patent for medical delivery system	01-19	AN
N4 Pharma touts contract to test glaucoma treatment, ECP105	01-16	AN
N4 Pharma Unit to Prepare Glaucoma Treatment Candidate for Pre-clinical Trials; Shares Plunge	01-16	MT
N4 Pharma Shows Increased Transduction Efficacy for Silica Nanoparticle	01-08	MT
N4 Pharma hails increased efficacy of Nuvec when complexed with AAV8	01-08	AN
N4 Pharma plc Provides A Further Successful Update on Its Ongoing Research Work into the Use of Nuvec to Enhance the Performance of Viral Vector	01-08	CI
FTSE 100 outperforms European peers	12-18	AN
N4 Pharma rises on successful results from Nuvec administration	12-18	AN
N4 Pharma Plc Provides Positive Update on its Ongoing Oral Delivery Research Work	12-18	CI

No results for this search